B-lymphoblastic leukemia/lymphoma with t(17;19) Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for B-lymphoblastic leukemia/lymphoma with t(17;19).

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for B-lymphoblastic leukemia/lymphoma with t(17;19).
Check the disease page for updates →

Approved Treatments

1 FDA-approved

IMBRUVICA

(ibrutinib)Orphan drugstandard

Pharmacyclics, LLC

Kinase Inhibitor [EPC]

12.1 Mechanism of Action Ibrutinib is a small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Ibrutinib forms a covalent bond with a cysteine re...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for B-lymphoblastic leukemia/lymphoma with t(17;19).
Search all trials →

Search clinical trials for B-lymphoblastic leukemia/lymphoma with t(17;19) →

Recent News & Research

No recent news articles indexed yet for B-lymphoblastic leukemia/lymphoma with t(17;19).
Search PubMed for B-lymphoblastic leukemia/lymphoma with t(17;19) →

Browse all B-lymphoblastic leukemia/lymphoma with t(17;19) news →

Specialist Network

No specialists currently listed for B-lymphoblastic leukemia/lymphoma with t(17;19).

View all B-lymphoblastic leukemia/lymphoma with t(17;19) specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰